Performance of a protein biomarker panel for prediction of cardiovascular events in patients with diabetes mellitus

Eur J Prev Cardiol. 2022 May 27;29(8):e270-e271. doi: 10.1093/eurjpc/zwac050.

Authors

Reza Mohebi^{1

2}, Cian P McCarthy^{1

2}, Craig A Magaret³, Grady Barnes³, Rhonda F Rhyne³, Celine Peters³, Hanna K Gaggin^{1

2}, James L Januzzi^{1

2

4}

Affiliations

¹ Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
² Harvard Medical School, 25 Shattuck Street Boston, MA 02115, USA.
³ Prevencio, Inc., 11335 NE 122nd Way, Kirkland, WA 98034, USA.
⁴ Baim Institute for Clinical Research, 930 Commonwealth Avenue #3, Boston, MA 02215, USA.

No abstract available

Keywords: Biomarker; Cardiovascular disease; Diabetes mellitus.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Biomarkers / metabolism
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / diagnosis
Diabetes Mellitus, Type 2* / epidemiology
Humans
Risk Factors

Substances

Biomarkers

Grants and funding

T32 HL094301/HL/NHLBI NIH HHS/United States